Annals of the Rheumatic Diseases

دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه

ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
~~قیمت : 3,800,000 تومان~~
قیمت ویژه : 1,900,000تومان

سفارش

Primary and secondary non-response: in need of operational definitions in observational studies

Enriqueta Vallejo-Yagüe, Edward C Keystone, Sreemanjari Kandhasamy, Raphael Micheroli, Axel Finckh, Andrea Michelle Burden

doi : 10.1136/annrheumdis-2021-220202

Annals of the Rheumatic Diseases 2021;80:961-964

خرید پکیج و مشاهده آنلاین مقاله

Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial

Veerle Stouten, René Westhovens, Sofia Pazmino, Diederik De Cock, Kristien Van der Elst, Johan Joly, Delphine Bertrand, Patrick Verschueren

doi : 10.1136/annrheumdis-2020-219825

Annals of the Rheumatic Diseases 2021;80:965-973

To compare outcomes of different treatment schedules from the care in early rheumatoid arthritis (CareRA) trial over 5 years.

خرید پکیج و مشاهده آنلاین مقاله

Tenosynovitis has a high sensitivity for early ACPA-positive and ACPA-negative RA: a large cross-sectional MRI study

Xanthe Marijn Edmée Matthijssen, Fenne Wouters, Navkiran Sidhu, Ellis Niemantsverdriet, Annette van der Helm-van Mil

doi : 10.1136/annrheumdis-2020-219302

Annals of the Rheumatic Diseases 2021;80:974-980

Clinically evident tenosynovitis can be seen in established rheumatoid arthritis (RA). Imaging research has recently shown that tenosynovitis at small joints occurs in early RA, contributes to typical RA symptoms (including joint swelling) and is infrequent in healthy controls. Imaging-detectable tenosynovitis is often not recognisable at joint examination, hence its prevalence can therefore be underestimated. We hypothesised that if MRI-detectable tenosynovitis is a true RA feature, the sensitivity for RA is high, in both anti-citrullinated protein antibodies (ACPA)-positive and ACPA-negative RA, and lower in other diseases that are associated with enthesitis (such as spondyloarthritis (SpA) and psoriatic arthritis (PsA)). So far, no large MRI study addressed these questions.

خرید پکیج و مشاهده آنلاین مقاله

Effects of RANKL inhibition on promoting healing of bone erosion in rheumatoid arthritis using HR-pQCT: a 2-year, randomised, double-blind, placebo-controlled trial

Ho So, Isaac T Cheng, Sze-Lok Lau, Evelyn Chow, Tommy Lam, Vivian W Hung, Edmund K Li, James F Griffith, Vivian W Lee, Lin Shi, Junbin Huang, Kitty Yan Kwok, Cheuk-Wan Yim, Tena K Li, Vincent Lo, Jolie Lee, Jack Jock-Wai Lee, Ling Qin, Lai-Shan Tam

doi : 10.1136/annrheumdis-2021-219846

Annals of the Rheumatic Diseases 2021;80:981-988

To evaluate the effects of denosumab on erosion healing at 2–4 metacarpophalangeal (MCP) head as determined by high-resolution peripheral quantitative CT (HR-pQCT) in patients with rheumatoid arthritis (RA) with stable disease.

خرید پکیج و مشاهده آنلاین مقاله

Circulating blood metabolite trajectories and risk of rheumatoid arthritis among military personnel in the Department of Defense Biorepository

Karen H Costenbader, Michael DiIorio, Su H Chu, Jing Cui, Jeffrey A Sparks, Bing Lu, LauraKay Moss, Lindsay Kelmenson, Marie Feser, Jess Edison, Clary Clish, Jessica Lasky-Su, Kevin D Deane, Elizabeth W Karlson

doi : 10.1136/annrheumdis-2020-219682

Annals of the Rheumatic Diseases 2021;80:989-996

We sought to identify metabolic changes potentially related to rheumatoid arthritis (RA) pathogenesis occurring in the blood prior to its diagnosis.

خرید پکیج و مشاهده آنلاین مقاله

Dynamical trajectory of glucocorticoids tapering and discontinuation in patients with rheumatoid arthritis commencing glucocorticoids with csDMARDs: a real-world data from 2009 to 2020

Wenhui Xie, Hong Huang, Guangtao Li, Yanjie Hao, Yanni Gui, Yu Wang, Xuerong Deng, Juan Zhao, Yan Geng, LanLan Ji, Xiaohui Zhang, Zhibo Song, Zhuoli Zhang

doi : 10.1136/annrheumdis-2021-220112

Annals of the Rheumatic Diseases 2021;80:997-1003

To unravel the dynamical trajectory and features of glucocorticoids (GC) tapering and discontinuation in patients with rheumatoid arthritis (RA) commencing GC with concomitant conventional synthetic disease-modifying antirheumatic drugs (csDMARDs).

خرید پکیج و مشاهده آنلاین مقاله

Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study

Atul Deodhar, Paula Sliwinska-Stanczyk, Huji Xu, Xenofon Baraliakos, Lianne S Gensler, Dona Fleishaker, Lisy Wang, Joseph Wu, Sujatha Menon, Cunshan Wang, Oluwaseyi Dina, Lara Fallon, Keith S Kanik, Désirée van der Heijde

doi : 10.1136/annrheumdis-2020-219601

Annals of the Rheumatic Diseases 2021;80:1004-1013

To assess the efficacy/safety of tofacitinib in adult patients with active ankylosing spondylitis (AS).

خرید پکیج و مشاهده آنلاین مقاله

Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 trial

James Cheng-Chung Wei, Tae-Hwan Kim, Mitsumasa Kishimoto, Naoki Ogusu, Haeyoun Jeong, Shigeto Kobayashi

doi : 10.1136/annrheumdis-2020-219406

Annals of the Rheumatic Diseases 2021;80:1014-1021

To investigate the efficacy and safety of brodalumab, a fully human anti-interleukin-17 receptor A monoclonal antibody, in patients with axial spondyloarthritis (axSpA).

خرید پکیج و مشاهده آنلاین مقاله

Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission: efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y)

Robert BM Landewé, Lianne S Gensler, Denis Poddubnyy, Proton Rahman, Maja Hojnik, Xiaoqi Li, Soyi Liu Leage, David Adams, Hilde Carlier, Filip Van den Bosch

doi : 10.1136/annrheumdis-2020-219717

Annals of the Rheumatic Diseases 2021;80:1022-1030

The objective of COAST-Y was to evaluate the effect of continuing versus withdrawing ixekizumab (IXE) in patients with axial spondyloarthritis (axSpA) who had achieved remission.

خرید پکیج و مشاهده آنلاین مقاله

Lysosome-associated membrane protein 3 misexpression in salivary glands induces a Sjögren’s syndrome-like phenotype in mice

Hiroyuki Nakamura, Tsutomu Tanaka, Thomas Pranzatelli, Youngmi Ji, Hongen Yin, Paola Perez, Sandra A Afione, Shyh-Ing Jang, Corrine Goldsmith, Chang Yu Zheng, William D Swaim, Blake M Warner, Noriyuki Hirata, Masayuki Noguchi, Tatsuya Atsumi, John A Chiorini

doi : 10.1136/annrheumdis-2020-219649

Annals of the Rheumatic Diseases 2021;80:1031-1039

Sjögren’s syndrome (SS) is an autoimmune sialadenitis with unknown aetiology. Although extensive research implicated an abnormal immune response associated with lymphocytes, an initiating event mediated by salivary gland epithelial cell (SGEC) abnormalities causing activation is poorly characterised. Transcriptome studies have suggested alternations in lysosomal function are associated with SS, but a cause and effect linkage has not been established. In this study, we demonstrated that altered lysosome activity in SGECs by expression of lysosome-associated membrane protein 3 (LAMP3) can initiate an autoimmune response with autoantibody production and salivary dysfunction similar to SS.

خرید پکیج و مشاهده آنلاین مقاله

Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes

Marialbert Acosta-Herrera, Martin Kerick, Elena Lopéz-Isac, Shervin Assassi, Lorenzo Beretta, Carmen Pilar Simeón-Aznar, Norberto Ortego-Centeno, International SSc Group, Susanna M Proudman, Australian Scleroderma Interest Group (ASIG), Nicolas Hunzelmann, Gianluca Moroncini, Jeska K de Vries-Bouwstra, Gisela Orozco, Anne Barton, Ariane L Herrick, Chikashi Terao, Yannick Allanore, Matthew A Brown, Timothy RDJ Radstake, Carmen Fonseca, Christopher P Denton, Maureen D Mayes, Javier Martin

doi : 10.1136/annrheumdis-2021-219884

Annals of the Rheumatic Diseases 2021;80:1040-1047

The greatest genetic effect reported for systemic sclerosis (SSc) lies in the major histocompatibility complex (MHC) locus. Leveraging the largest SSc genome-wide association study, we aimed to fine-map this region to identify novel human leucocyte antigen (HLA) genetic variants associated with SSc susceptibility and its main clinical and serological subtypes.

خرید پکیج و مشاهده آنلاین مقاله

X-linked inhibitor of apoptosis protein (XIAP) inhibition in systemic sclerosis (SSc)

Christina Bergmann, Ludwig Hallenberger, Sara Chenguiti Fakhouri, Benita Merlevede, Amelie Brandt, Clara Dees, Honglin Zhu, Ariella Zehender, Xiang Zhou, Annemarie Schwab, Chih-Wei Chen, Andrea Hermina Györfi, Alexandru Emil Matei, Debomita Chakraborty, Thuong Trinh-Minh, Simon Rauber, Roland Coras, Aline Bozec, Alexander Kreuter, Mirjana Ziemer, Georg Schett, Jörg H W Distler

doi : 10.1136/annrheumdis-2020-219822

Annals of the Rheumatic Diseases 2021;80:1048-1056

X-linked inhibitor of apoptosis protein (XIAP) is a multifunctional protein with important functions in apoptosis, cellular differentiation and cytoskeletal organisation and is emerging as potential target for the treatment of various cancers. The aim of the current study was to investigate the role of XIAP in the pathogenesis of systemic sclerosis (SSc).

خرید پکیج و مشاهده آنلاین مقاله

Pathogenic UBA1 variants associated with VEXAS syndrome in Japanese patients with relapsing polychondritis

Naomi Tsuchida, Yosuke Kunishita, Yuri Uchiyama, Yohei Kirino, Makiko Enaka, Yukie Yamaguchi, Masataka Taguri, Shoji Yamanaka, Kaoru Takase-Minegishi, Ryusuke Yoshimi, Satoshi Fujii, Hideaki Nakajima, Naomichi Matsumoto

doi : 10.1136/annrheumdis-2021-220089

Annals of the Rheumatic Diseases 2021;80:1057-1061

To determine clinical and genetic features of individuals with relapsing polychondritis (RP) likely caused by pathogenic somatic variants in ubiquitin-like modifier activating enzyme 1 (UBA1).

خرید پکیج و مشاهده آنلاین مقاله

Long-term structural and symptomatic effects of intra-articular sprifermin in patients with knee osteoarthritis: 5-year results from the FORWARD study

Felix Eckstein, Marc C Hochberg, Hans Guehring, Flavie Moreau, Victor Ona, Asger Reinstrup Bihlet, Inger Byrjalsen, Jeppe Ragnar Andersen, Benjamin Daelken, Oliver Guenther, Christoph Ladel, Martin Michaelis, Philip G Conaghan

doi : 10.1136/annrheumdis-2020-219181

Annals of the Rheumatic Diseases 2021;80:1062-1069

The FORWARD (FGF-18 Osteoarthritis Randomized Trial with Administration of Repeated Doses) trial assessed efficacy and safety of the potential disease-modifying osteoarthritis drug (DMOAD) sprifermin in patients with knee osteoarthritis. Here, we report 5-year efficacy and safety results.

خرید پکیج و مشاهده آنلاین مقاله

Linking chondrocyte and synovial transcriptional profile to clinical phenotype in osteoarthritis

Julia Steinberg, Lorraine Southam, Andreas Fontalis, Matthew J Clark, Raveen L Jayasuriya, Diane Swift, Karan M Shah, Roger A Brooks, Andrew W McCaskie, Jeremy Mark Wilkinson, Eleftheria Zeggini

doi : 10.1136/annrheumdis-2020-219760

Annals of the Rheumatic Diseases 2021;80:1070-1074

To determine how gene expression profiles in osteoarthritis joint tissues relate to patient phenotypes and whether molecular subtypes can be reproducibly captured by a molecular classification algorithm.

خرید پکیج و مشاهده آنلاین مقاله

Novel self-amplificatory loop between T cells and tenocytes as a driver of chronicity in tendon disease

Emma Garcia-Melchor, Giacomo Cafaro, Lucy MacDonald, Lindsay A N Crowe, Shatakshi Sood, Michael McLean, Umberto G Fazzi, Iain B McInnes, Moeed Akbar, Neal L Millar

doi : 10.1136/annrheumdis-2020-219335

Annals of the Rheumatic Diseases 2021;80:1075-1085

Increasing evidence suggests that inflammatory mechanisms play a key role in chronic tendon disease. After observing T cell signatures in human tendinopathy, we explored the interaction between T cells and tendon stromal cells or tenocytes to define their functional contribution to tissue remodelling and inflammation amplification and hence disease perpetuation.

خرید پکیج و مشاهده آنلاین مقاله

Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study

Hannah Bower, Thomas Frisell, Daniela Di Giuseppe, Bénédicte Delcoigne, Gerd-Marie Ahlenius, Eva Baecklund, Katerina Chatzidionysiou, Nils Feltelius, Helena Forsblad-d'Elia, Alf Kastbom, Lars Klareskog, Elisabet Lindqvist, Ulf Lindström, Carl Turesson, Christopher Sjöwall, Johan Askling

doi : 10.1136/annrheumdis-2021-219845

Annals of the Rheumatic Diseases 2021;80:1086-1093

To estimate absolute and relative risks for all-cause mortality and for severe COVID-19 in inflammatory joint diseases (IJDs) and with antirheumatic therapies.

خرید پکیج و مشاهده آنلاین مقاله

Patient research partner involvement in rheumatology clinical trials: analysis of journal articles 2016–2020

Huixin Wang, Sarah Stewart, Ben Darlow, Ben Horgan, Graham Hosie, Jane Clark, Nicola Dalbeth

doi : 10.1136/annrheumdis-2021-220138

Annals of the Rheumatic Diseases 2021;80:1095-1096

خرید پکیج و مشاهده آنلاین مقاله

Onset of rheumatoid arthritis after COVID-19: coincidence or connected?

Veerle F A M Derksen, Theresa Kissel, Femke B G Lamers-Karnebeek, Arie E van der Bijl, Annemarie C Venhuizen, Tom W J Huizinga, René E M Toes, Anna H E Roukens, Diane van der Woude

doi : 10.1136/annrheumdis-2021-219859

Annals of the Rheumatic Diseases 2021;80:1096-1098

خرید پکیج و مشاهده آنلاین مقاله

Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases

Brian J Boyarsky, Jake A Ruddy, Caoilfhionn M Connolly, Michael T Ou, William A Werbel, Jacqueline M Garonzik-Wang, Dorry L Segev, Julie J Paik

doi : 10.1136/annrheumdis-2021-220289

Annals of the Rheumatic Diseases 2021;80:1098-1099

خرید پکیج و مشاهده آنلاین مقاله

Safety of?the?first?dose of?mRNA SARS-CoV-2?vaccines in?patients with rheumatic and musculoskeletal diseases

Caoilfhionn M Connolly, Jake A Ruddy, Brian J Boyarsky, Robin K Avery, William A Werbel, Dorry L Segev, Jacqueline Garonzik-Wang, Julie J Paik

doi : 10.1136/annrheumdis-2021-220231

Annals of the Rheumatic Diseases 2021;80:1100-1101

خرید پکیج و مشاهده آنلاین مقاله

SARS-CoV-2 infection among inpatients with systemic lupus erythematosus in France: a nationwide epidemiological study

Arthur Mageau, Geoffrey Aldebert, Damien Van Gysel, Thomas Papo, Jean-François Timsit, Karim Sacre

doi : 10.1136/annrheumdis-2021-220010

Annals of the Rheumatic Diseases 2021;80:1101-1102

خرید پکیج و مشاهده آنلاین مقاله

Second COVID-19 infection in a patient with granulomatosis with polyangiitis on rituximab

Marcia A Friedman, Kevin L Winthrop

doi : 10.1136/annrheumdis-2021-220088

Annals of the Rheumatic Diseases 2021;80:1102-1104

خرید پکیج و مشاهده آنلاین مقاله

New 2019 SLE EULAR/ACR classification criteria are valuable for distinguishing patients with SLE from patients with pSS

Florence Assan, Raphaele Seror, Xavier Mariette, Gaetane Nocturne

doi : 10.1136/annrheumdis-2019-216222

Annals of the Rheumatic Diseases 2021;80:e122

خرید پکیج و مشاهده آنلاین مقاله

Response to: ‘New 2019 SLE EULAR/ACR classification criteria are valuable for distinguishing patients with SLE from patients with pSS’ by Assan et al

Martin Aringer, Karen Costenbader, Thomas Dörner, Sindhu R Johnson

doi : 10.1136/annrheumdis-2019-216250

Annals of the Rheumatic Diseases 2021;80:e123

خرید پکیج و مشاهده آنلاین مقاله

Role of ANA testing in the classification of patients with systemic lupus erythematosus

David S Pisetsky1,2, Diane M Spencer1,2, Brad Rovin3, Peter E Lipsky

doi : 10.1136/annrheumdis-2019-216259

Annals of the Rheumatic Diseases 2021;80:e124

خرید پکیج و مشاهده آنلاین مقاله

Response to: ‘Role of ANA testing in the classification of patients with systemic lupus erythematosus’ by Pisetsky et al

Martin Aringer, Karen H Costenbader, Thomas Dörner, Sindhu R Johnson

doi : 10.1136/annrheumdis-2019-216337

Annals of the Rheumatic Diseases 2021;80:e125

خرید پکیج و مشاهده آنلاین مقاله

Do the 2019 EULAR/ACR SLE classification criteria close the door on certain groups of SLE patients?

Huihui Chi, Jialin Teng, Zhihong Wang, Chengde Yang, Yutong Su

doi : 10.1136/annrheumdis-2019-216253

Annals of the Rheumatic Diseases 2021;80:e126

خرید پکیج و مشاهده آنلاین مقاله

Response to: ‘Do the 2019 EULAR/ACR SLE classification criteria close the door on certain groups of SLE patients?’ by Chi et al

Martin Aringer, Karen H Costenbader, Thomas Dörner, Sindhu R Johnson

doi : 10.1136/annrheumdis-2019-216338

Annals of the Rheumatic Diseases 2021;80:e127

خرید پکیج و مشاهده آنلاین مقاله

Titre-specific positive predictive value of antinuclear antibody patterns

Jean-Baptiste Vulsteke, Lieve Van Hoovels, Philippe Willems, Bert Vander Cruyssen, Steven Vanderschueren, Rene Westhovens, Daniel Blockmans, Ellen De Langhe, Xavier Bossuyt

doi : 10.1136/annrheumdis-2019-216245

Annals of the Rheumatic Diseases 2021;80:e128

خرید پکیج و مشاهده آنلاین مقاله